These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12024010)

  • 1. Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant.
    Lemm I; Ross J
    Mol Cell Biol; 2002 Jun; 22(12):3959-69. PubMed ID: 12024010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
    Sparanese D; Lee CH
    Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.
    Weidensdorfer D; Stöhr N; Baude A; Lederer M; Köhn M; Schierhorn A; Buchmeier S; Wahle E; Hüttelmaier S
    RNA; 2009 Jan; 15(1):104-15. PubMed ID: 19029303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides.
    Coulis CM; Lee C; Nardone V; Prokipcak RD
    Mol Pharmacol; 2000 Mar; 57(3):485-94. PubMed ID: 10692488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
    Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
    J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of ribosome bound nascent polypeptides in vitro to identify translational pause sites along mRNA.
    Jha SS; Komar AA
    J Vis Exp; 2012 Jul; (65):. PubMed ID: 22806127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
    Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
    Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
    Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
    Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Ribosomal Pausing by eIF5A Is Necessary to Maintain the Fidelity of Start Codon Selection.
    Manjunath H; Zhang H; Rehfeld F; Han J; Chang TC; Mendell JT
    Cell Rep; 2019 Dec; 29(10):3134-3146.e6. PubMed ID: 31801078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of the contribution of c-myc mRNA constituents upon cap and IRES mediated translation.
    Meristoudis C; Trangas T; Lambrianidou A; Papadopoulos V; Dimitriadis E; Courtis N; Ioannidis P
    Biol Chem; 2015 Dec; 396(12):1301-13. PubMed ID: 26351916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival.
    Lambrianidou A; Sereti E; Soupsana K; Komini C; Dimas K; Trangas T
    Cell Signal; 2021 Apr; 80():109912. PubMed ID: 33388443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
    Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
    Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA.
    Barnes T; Kim WC; Mantha AK; Kim SE; Izumi T; Mitra S; Lee CH
    Nucleic Acids Res; 2009 Jul; 37(12):3946-58. PubMed ID: 19401441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
    Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
    J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of an mRNA-binding protein in human colorectal cancer.
    Ross J; Lemm I; Berberet B
    Oncogene; 2001 Oct; 20(45):6544-50. PubMed ID: 11641779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Control through Differential Ribosome Pausing during Amino Acid Limitation in Mammalian Cells.
    Darnell AM; Subramaniam AR; O'Shea EK
    Mol Cell; 2018 Jul; 71(2):229-243.e11. PubMed ID: 30029003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA.
    Prokipcak RD; Herrick DJ; Ross J
    J Biol Chem; 1994 Mar; 269(12):9261-9. PubMed ID: 8132663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Myc 5' untranslated region contains an internal ribosome entry segment.
    Stoneley M; Paulin FE; Le Quesne JP; Chappell SA; Willis AE
    Oncogene; 1998 Jan; 16(3):423-8. PubMed ID: 9467968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.